Search Results - "Brahmi, M."

NTRK fusion in soft tissue sarcomas harboring MDM2/CDK4 amplification: three case reports by Brahmi, M., Dufresne, A., Verret, B., Tirode, F., Blay, J.Y.

Get full text

Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement by Guinot, A., Tabone-Eglinger, S., Isnardi, V., Bahri, H., Surdez, D., Delattre, O., Pierron, G., Villemeur, M., Lapouble, E., Brahmi, M., Bouhamama, A., Corradini, N., Marec-Bérard, Perrine

“…Ewing sarcoma (ES) is an aggressive bone or extraosseous tumour with an unfavourable prognosis when bone marrow metastases are present at diagnosis. The gold…”
Get full text

Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene by Brahmi, M., Alberti, L., Tirode, F., Karanian, M., Eberst, L., Pissaloux, D., Cassier, P., Blay, J.Y.

Get full text

French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak by Penel, N., Bonvalot, S., Minard, V., Orbach, D., Gouin, F., Corradini, N., Brahmi, M., Marec-Bérard, P., Briand, S., Gaspar, N., Llacer, C., Carrère, S., Dufresne, A., Le Cesne, A., Blay, J.Y.

Get full text

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma by Dufresne, A., Lesluyes, T., Ménétrier-Caux, C., Brahmi, M., Darbo, E., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Le Guellec, S., Valentin, T., Chevreau, C., Bonvalot, S., Robin, Y.M., Coindre, J-M, Caux, C., Blay, J.Y., Chibon, F.

“…Soft tissue sarcomas are a group of rare and aggressive connective tissue neoplasms for which curative therapeutic opportunities are limited in advanced phase…”
Get full text

Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor by Verspoor, F. G. M., Mastboom, M. J. L., Hannink, G., Maki, R. G., Wagner, A., Bompas, E., Desai, J., Italiano, A., Seddon, B. M., van der Graaf, W. T. A., Blay, J.-Y., Brahmi, M., Eberst, L., Stacchiotti, S., Mir, O., van de Sande, M. A. J., Gelderblom, H., Cassier, P. A.

“…Tenosynovial giant cell tumors (TGCT), are rare colony stimulating factor-1(CSF-1)-driven proliferative disorders affecting joints. Diffuse-type TGCT often…”
Get full text

Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years by Blay, JY, Piperno-Neumann, S., Watson, S., Dufresne, A., Valentin, T., Duffaud, F., Toulmonde, M., Italiano, A., Bertucci, F., Tlemsani, C., Firmin, N., Bompas, E., Perrin, C., Ropars, M., Saada-Bouzid, E., Dubray-Longeras, P., Hervieu, A., Lebbe, C., Gantzer, J., Chaigneau, L., Fiorenza, F., Rios, M., Isambert, N., Soibinet, P., Boudou-Roquette, P., Verret, B., Ferron, G., Ryckewaert, T., Lebellec, L., Brahmi, M., Gouin, F., Meeus, P., Vaz, G., Le Loarer, F., Karanian, M., De Pinieux, G., Ducimetiere, F., Chemin, C., Morelle, M., Le Cesne, A., Penel, N.

“…Epithelioid hemangioendothelioma (EHE) is an ultrarare sarcoma whose natural history and treatment is not well defined. We report on the presentation and…”
Get full text

Dam parity and calf sex affect maternal and neonatal behaviors during the first week postpartum in stabled Maghrebi dairy camels by Hammadi, I., Chniter, M., Atigui, M., Brahmi, M., Seddik, M.M., Salem, W.B., Lévy, F., Nowak, R., Hammadi, M.

“…Currently, a trend toward the commercialization of dromedary milk associated with recent intensive rearing systems has starting worldwide which impose…”
Get full text

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years by Blay, J Y, Tlemsani, C, Toulmonde, M, Italiano, A, Rios, M, Bompas, E, Valentin, T, Duffaud, F, Le Nail, L R, Watson, S, Firmin, N, Dubray-Longeras, P, Ropars, M, Perrin, C, Hervieu, A, Lebbe, C, Saada-Bouzid, E, Soibinet, P, Fiorenza, F, Bertucci, F, Boudou, P, Vaz, G, Bonvalot, S, Honoré, C, Marec-Berard, P, Minard, V, Cleirec, M, Biau, D, Meeus, P, Babinet, A, Dumaine, V, Carriere, S, Fau, M, Decanter, G, Gouin, F, Ngo, C, Le Loarer, F, Karanian, M, Meurgey, A, Dufresne, A, Brahmi, M, Chemin-Airiau, C, Ducimetiere, F, Penel, N, Le Cesne, A

“…Sclerosing Epithelioid Fibrosarcoma (SEF) and Low Grade Fibromyxoid Sarcoma (LGFMS) are ultrarare sarcomas sharing common translocations whose natural history…”
Get full text

Chemical Composition, in vitro Antioxidant, Antimicrobial and Cytotoxic Activities of Mentha spicata Essential Oil: A Review by Adli, D.E., Brahmi, M., Ziani, K., Brahmi, K., Kahloula, K., Slimani, M.

“…This work is a review of the results of some studies conducted around the world on the essential oil of Mentha spicata . Thus, chemical analysis by gas…”
Get full text

Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors by Dufresne, A., Pissaloux, D., Ngo, C., Penel, N., Le Cesne, A., Macagno, N., Vanacker, H., Hénon, C., Jean-Denis, M., Rughoo, K., Tirode, F., Blay, J.-Y., Brahmi, M.

“…Apart for infantile fibrosarcoma (IFS), very little is known about NTRK-rearranged mesenchymal tumors (NMTs). The objective of this study is to describe the…”
Get full text

Proof-of-concept study evaluating a new tool for standardising radiological assessment of tumour response to treatment in routine clinical practice by Mastier, C., de la Fouchardière, C., Fayette, J., Sarabi, M., Heudel, P., Coulon, A., Banaste, N., Mercier-Bischoff, E., Barma, M., Brahmi, M., Cassier, P., Couchon Thaunat, S., Eberst, L., Fournier-Garin, G., Metral, P., Pilleul, F., Blay, J.-Y.

Get full text

mTOR inhibitors in uterine and extra-uterine malignant PEComas: A multicenter international case series retrospective analysis by Sanfilippo, R., Jones, R.L., Provenzano, S., Antoniou, G., Blay, J.-Y., Fumagalli, E., Stacchiotti, S., Bertulli, R.M., Mir, O., Hindi, N., Brahmi, M., Dufresne, A., Dei Tos, A.P., Casali, P.G.

Get full text

Antimicrobial and Antiochratoxic Activities of Mentha spicata Essential Oil by Brahmi, M., Adli, D.E.H., Boufadi, M.Y., Arabi, W., Kahloula, K., Slimani, M.

“…The principle aim of this work is to evaluate the antimicrobial and antiochratoxic power of the essential oil of Mentha spicata (EOM). This oil was obtained by…”
Get full text

Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network by Smrke, A., Frezza, A.M., Giani, C., Somaiah, N., Brahmi, M., Czarnecka, A.M., Rutkowski, P., Van der Graaf, W., Baldi, G.G., Connolly, E., Duffaud, F., Huang, P.H., Gelderblom, H., Bhadri, V., Grimison, P., Mahar, A., Stacchiotti, S., Jones, R.L.

“…Clear cell sarcoma (CCS) is a translocated aggressive malignancy with a high incidence of metastases and poor prognosis. There are few studies describing the…”
Get full text

Correlation between an automated functional assay that predicts targeted agent (TA) sensitivity and the tumor response of the sorafenib treatment evaluated within the MOST clinical trial by Tredan, O., Zelichov, O., Barbash, Z., Daitsh, Y., Birnbaum, L., Tarcic, G., You, B., Cassier, P., de la Fouchardiere, C., Ray-Coquard, I.L., Brahmi, M., Wang, Q., Attignon, V., Baudet, C., Fournier Garin, G., Agrapart, V., Dargenio, A., Chabaud, S., Perol, D., Blay, J.-Y.

Get full text

Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG) by Moreau-Bachelard, C., Campion, L., Toulmonde, M., Le Cesne, A., Brahmi, M., Italiano, A., Mir, O., Piperno-Neumann, S., Laurence, V., Firmin, N., Penel, N., Duffaud, F., Chevreau, C., Bertucci, F., Narciso, B., Dubray-Longeras, P., Delcambre, C., Saada-Bouzid, E., Boudou-Rouquette, P., Soulie, P., Perrin, C., Blay, J.Y., Bompas, E.

“…Synovial sarcoma (SS) occurs in both adult and pediatric patients. The primary aim of this study is to describe the outcomes, prognostic factors, and treatment…”
Get full text

Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry by Hindi, N, Razak, A, Rosenbaum, E, Jonczak, E, Hamacher, R, Rutkowski, P, Bhadri, V A, Skryd, A, Brahmi, M, Alshibany, A, Jagodzinska-Mucha, P, Bauer, S, Connolly, E, Gelderblom, H, Boye, K, Henon, C, Bae, S, Bogefors, K, Vincenzi, B, Martinez-Trufero, J, Lopez-Martin, J A, Redondo, A, Valverde, C, Blay, J-Y, Moura, D S, Gutierrez, A, Tap, W, Martin-Broto, J

“…Conventional cytotoxic drugs are not effective in alveolar soft-part sarcoma (ASPS). Immune checkpoint (programmed cell death protein 1/programmed death-ligand…”
Get full text

Apriori to agricultural problems emerged through participatory rural appraisal in temperate zone of the Himalayas by JOSHI, A K, BRAHMI, M K, GUPTA, B K, KUMAR, PRAMOD, THAKUR, PRIYANKA, CHAUHAN, V K

“…The participatory rural appraisals were exercised during 2014 in temperate Himalayas in eight gram panchayats of Sangrah block of district Sirmour of Himachal…”
Get full text

Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas by Brahmi, M., Lesluyes, T., Dufresne, A., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Valentin, T., Chevreau, C., Bonvalot, S., Penel, N., Coindre, J.-M., Le Guellec, S., Le Loarer, F., Karanian, M., Blay, J.-Y., Chibon, F.

“…While the anti-PDGFRA antibody olaratumab failed to confirm an impact on survival in unselected advanced soft tissue sarcoma (STS) patients, the level of…”
Get full text